The Potential for Dose Dumping in Normal Tissues with IMRT for Pelvic and H&N Cancers

Medical Dosimetry

Volumn 33, Issue 1, 2008, Pages 55-61

  Reddy, Nandanuri M S ^a   Mazur, Andrzej K ^a   Sampath, Seshadri ^a   Osian, Adrian ^a   Sood, Brij M ^a,b   Ravi, Akkamma ^a,b   Nori, Dattatreyudu ^a,b  

^a NEW YORK HOSPITAL QUEENS   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Dose dumping; H N and pelvic cancers; IMRT; Normal tissues

Indexed keywords

ARTICLE; BLADDER; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PELVIS CANCER; PHANTOM; PHOTON; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; RADIATION RESPONSE; RECTUM; TREATMENT PLANNING; UTERINE CERVIX CANCER;

BODY BURDEN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PELVIC NEOPLASMS; RADIATION INJURIES; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RELATIVE BIOLOGICAL EFFECTIVENESS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 38849128090     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2007.05.001     Document Type: Article

References (26)

1. Burman C., Chui C.-S., Kutcher G., et al. Planning, delivery and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys 39 (1977) 863-873
2. Mohan R., Wu Q., Manning M., et al. Radiobiological considerations in the design of fractionation strategies for intensity modulated radiation therapy of head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys 46 (2000) 619-630
3. Wu Q., Manning M., Schmidt-Ulrich, et al. The potential for sparing of parotid and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A treatment design study. Int. J. Radiat. Oncol. Biol. Phys 46 (2000) 195-205
4. Mohan D.S., Kupelian P.A., and Willoughby T.R. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. Int. J. Radiat. Oncol. Biol. Phys 46 (2000) 575-580
5. Dogan N., King S., Emami B., et al. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int. J. Radiat. Oncol. Biol. Phys 57 (2003) 1480-1491
6. Galvin J.M., Ezzell G., Eisbrach A., et al. Implementing IMRT clinical practice: A joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int. J. Radiat. Oncol. Biol. Phys 58 (2004) 1616-1634
7. Boyer A., Butler, DiPetrillo, et al. Intensity-modulated Rradiotherapy: Current status and issues of interest. Intensity Modulated Radiation Therapy Collaborative Working Group. Int. J. Radiat. Oncol. Biol. Phys 51 (2001) 880-914
8. Ezzell, Galvin J.M., Low D., et al. Guidance documentation on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT subcommittee of the AAPM radiation therapy committee. Med. Phys 30 (2003) 2089-2115
9. Cheng J.C., Wu J.K., Huang C.M., et al. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Int. J. Radiat. Oncol. Biol. Phys 56 (2003) 229-234
10. Lief E.P., DeWyngaert J.K., Lymbers S.C., et al. Accelerated concomitant boost. Emerging technology. In: Mundt A.J., and Roeske J.C. (Eds). Intensity Modulated Radiation Therapy. A Clinical Perspective (2004), BC Decker Inc, London 398-406
11. Scrimger R.A., Tome W.A., Olivia G.H., et al. Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancers, in comparison to conventional field arrangements. Am. J. Clin. Oncol (CCT) 26 (2003) 70-78
12. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer (II): Volume effects and dose-volume histograms. Int. J. Radiat. Oncol. Biol. Phys 49 (2001) 685-698
13. Fiorino C., Vavassori V., Sanguineti G., et al. Rectum contouring variability in patients treated for prostate cancer: Impact on rectum dose-volume histograms and normal tissue complication probability. Radiother. Oncol 63 (2002) 249-255
14. Foppiano F., Fiorino C., Frezza G., et al. The impact of contouring uncertainty on rectal 3D dose-volume data: Results of a dummy run in a multicenter trial (AIROPROS01-02). Int. J. Radiat. Oncol. Biol. Phys 57 (2003) 573-579
15. Reddy N.M., Sood B.M., and Nori D. Factors influencing the dose to rectum during the treatment of prostate with IMRT. Int. J. Radiat. Oncol. Biol. Phys 60 Suppl 1 (2004) S591 (Abstr)
16. Reddy N., Sood B.M., Mazur A., et al. Comparison of dose to rectum and bladder with 3DCRT and IMRT plans for the treatment of prostate. Med. Phys 32 (2005) 1964
17. Reddy N., Sood B.M., Sampath S., et al. Single course IMRT plan to deliver 45 Gy to seminal vesicles and 81 Gy to prostate in 45 fractions. Technol. Cancer Res. Treat 5 (2006) 503-512
18. D'Souza W.N., and Rosen I.I. Nontumor integral dose variation in conventional radiotherapy treatment planning. Med. Phys 30 (2003) 2065-2071
19. Hall E.J., and Wuu C.S. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys 56 (2003) 83-88
20. Skala M., Holloway L., Bailey M., et al. Australia-wide comparison of intensity modulated radiation therapy prostate plans. Australian Radiol 49 (2005) 222-229
21. Aoyama H., Westerly D.C., Mackie T.R., et al. Integral radiation dose to normal structures with conformal external beam radiation. Int. J. Radiat. Oncol. Biol. Phys 64 (2006) 962-967
22. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int. J. Radiat. Oncol. Biol. Phys 65 (2006) 1-7
23. Coselmon M.G., Moran J.M., Radawski J.D., et al. Improving IMRT delivery efficiency using intensity limits during inverse planning. Med. Phys 32 (2005) 1234-1245
24. Pirzkall A., Carol M.P., Pickett B., et al. The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets. Int. J. Radiat. Oncol. Biol. Phys 53 (2002) 434-442
25. Lee N., Chuang C., Quivey J.M., et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int. J. Radiat. Oncol. Biol. Phys 53 (2002) 630-637
26. Chao K.S.C., Ozyigit G., and Thorsdad W.L. Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of Amifostine. Semin. Oncol 30 (2003) 101-108